FRISINA, Nicola
 Distribuzione geografica
Continente #
EU - Europa 7.875
NA - Nord America 7.248
AS - Asia 3.799
SA - Sud America 1.272
AF - Africa 93
Continente sconosciuto - Info sul continente non disponibili 64
OC - Oceania 7
Totale 20.358
Nazione #
US - Stati Uniti d'America 7.106
RU - Federazione Russa 4.004
SG - Singapore 1.484
CN - Cina 1.295
BR - Brasile 1.084
SE - Svezia 959
IE - Irlanda 917
DE - Germania 564
UA - Ucraina 398
HK - Hong Kong 392
FI - Finlandia 257
FR - Francia 239
VN - Vietnam 223
GB - Regno Unito 207
IT - Italia 156
IN - India 91
CA - Canada 72
AR - Argentina 57
BD - Bangladesh 46
TR - Turchia 45
PL - Polonia 41
EC - Ecuador 34
IQ - Iraq 34
VE - Venezuela 32
MX - Messico 31
BE - Belgio 29
ZA - Sudafrica 26
JP - Giappone 23
CZ - Repubblica Ceca 19
PK - Pakistan 18
CO - Colombia 17
ID - Indonesia 16
IR - Iran 16
MA - Marocco 16
UY - Uruguay 14
AT - Austria 13
UZ - Uzbekistan 13
CL - Cile 12
KE - Kenya 11
NL - Olanda 11
NP - Nepal 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
EG - Egitto 10
ES - Italia 10
JO - Giordania 10
CR - Costa Rica 9
PE - Perù 9
AZ - Azerbaigian 7
CI - Costa d'Avorio 7
MY - Malesia 7
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LT - Lituania 6
PA - Panama 6
PT - Portogallo 6
PY - Paraguay 6
AL - Albania 5
BG - Bulgaria 5
BO - Bolivia 5
IL - Israele 5
JM - Giamaica 5
OM - Oman 5
PH - Filippine 5
SA - Arabia Saudita 5
SN - Senegal 5
AU - Australia 4
CH - Svizzera 4
RO - Romania 4
DK - Danimarca 3
EE - Estonia 3
EU - Europa 3
GE - Georgia 3
HN - Honduras 3
MN - Mongolia 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
RS - Serbia 3
BN - Brunei Darussalam 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
KR - Corea 2
LK - Sri Lanka 2
LV - Lettonia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
GI - Gibilterra 1
HU - Ungheria 1
KH - Cambogia 1
Totale 20.283
Città #
Moscow 1.154
Dublin 917
Ashburn 880
Jacksonville 850
Singapore 790
Chandler 778
Dallas 623
Nyköping 456
Beijing 439
Hong Kong 390
San Jose 349
Council Bluffs 204
The Dalles 197
Munich 177
Los Angeles 169
Cambridge 150
Princeton 150
Lauterbourg 141
Medford 141
Des Moines 120
Ann Arbor 114
New York 111
Boardman 108
Dearborn 86
São Paulo 74
Ho Chi Minh City 72
Helsinki 70
Buffalo 65
Santa Clara 65
Lancaster 61
Bremen 52
Hanoi 52
Tianjin 51
Shenyang 48
Guangzhou 47
Jinan 47
Wilmington 47
Woodbridge 45
Frankfurt am Main 39
Turku 34
Redondo Beach 33
Zhengzhou 32
Belo Horizonte 30
Rio de Janeiro 30
Orem 29
Brussels 28
Hebei 28
San Mateo 27
Atlanta 26
Houston 26
Nanjing 26
Warsaw 24
Montreal 23
Turin 23
Pune 22
Taizhou 22
Haikou 21
Shanghai 21
Boston 20
Chennai 20
Denver 20
Hangzhou 20
Johannesburg 20
San Francisco 20
Tokyo 20
Ningbo 19
Augusta 18
Düsseldorf 18
Ottawa 18
Columbus 17
Curitiba 17
Poplar 17
Porto Alegre 17
Seattle 17
Brno 16
London 16
Mumbai 16
Quito 16
Campinas 15
Chicago 15
Stockholm 15
Brooklyn 14
Baghdad 13
Changsha 13
Guayaquil 13
Lanzhou 13
Taiyuan 13
Nanchang 12
Santo André 12
Falls Church 11
Jiaxing 11
Shenzhen 11
Amman 10
Ardabil 10
Brasília 10
Istanbul 10
Leawood 10
Nuremberg 10
Recife 10
Tashkent 10
Totale 11.457
Nome #
Circadian rhythm of hydration in healthy subjects and uremic patients studied by bioelectrical impedance analysis 324
Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds 313
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 298
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 244
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 241
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 224
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 205
Cell proliferation/cell death balance in renal cell cultures after exposure to a static magnetic field 203
AQP1 in red blood cells of uremic patients during hemodialytic treatment 202
Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. 202
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 197
Aquaporin-2 water channels in spontaneously hypertensive rats 197
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 194
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 193
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 192
Does captopril have a direct pro-apoptotic effect? 188
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 188
Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock 187
Cardiovascular effects of raloxifene hydrochloride 186
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 185
Alterations in induced potassium calcium efflux in the erythrocytes of patients with autosomal dominant polycystic kidney disease and hypertension 185
Are there potential non-lipid-lowering uses of statins in the kidney? 185
Effects of Homocysteine on Proliferation, Necrosis, and Apoptosis of Vascular Smooth Muscle Cells in Culture and Influence of Folic Acid 184
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 181
Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients 180
Correlation between quality of life assessment and a personality neurobiologic model in dialyzed patients 180
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 178
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 176
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 176
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 173
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 173
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 170
Cardiorenal consequences of atherosclerosis and statins therapy: From the past to the future 170
A trigonometric approximation method for the monostatic radar cross section 169
Cold pressor test raises serum concentrations of ICAM-1, VCAM- 1, and E-selectin in normotensive and hypertensive patients 166
Recombinant erythropoietin and hypertension 165
Chromosomal damage and atherosclerosis. A protective effect from simvastatin. 165
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 165
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 163
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 161
Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension 159
Effetti dell'alendronato sul Sister Chromatid Exchanges (SCE) in pazienti con osteoporosi post-menopausale (dati preliminari). 159
Effect of two different models of hemodiafiltration potassium removal on QT dispersion 157
The effect of two different protocols of potassium haemodiafiltration on QT dispersion 156
Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study 155
Oxidative stress and uremia 153
Effect of a prostacyclin analogue, iloprost, on urinary aquaporin-2 excretion in humans 152
Therapy with vasopressin receptor antagonists: the aquaretics 151
Hashimoto's thyroiditis is a frequent association of primary hyperparathyroidism, of which it modifies biochemical and bone density indices 150
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 150
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 150
Effetti di un fitoestrogeno (Genisteina) su marcatori citogenetici in donne in post menopausa. 150
Aldosterone and prolactin secretion. II. Plasma renin activity, blood potassium and cortisol levels following administration of sulpiride in normal subjects 149
Statins in the prevention of cardiovascular events in patients with renal failure. 148
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 148
Statins in nephrotic syndrome: a new weapon against tissue injury. 148
Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. 147
Hashimoto's thyroiditis (HT) is a frequent association of primary hyperparathyroidism (p-hyperPTH), of which it modifies biochemical and bone density indices 145
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 145
Effect of unsaturated fatty acids on basal plasma renin activity and afterpostural stimulation 145
EFFICACY AND TOLERABILITY OF AURANOFIN IN RHEUMATOID-ARTHRITIS - 2 YEARS FOLLOW-UP 145
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 145
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 144
Increased indexes of thrombin activation in advanced stages of hypertension 144
ATTIVITÀ RENINICA, ANGIOTENSINA II, ALDOSTERONE PLASMATICI IN SOGGETTI ANZIANI. 144
Erythropoietin and the brain: from neurodevelopment to neuroprotection 143
Nonrobertsonian translocation t(6;11) is associated with infertility in an oligoazoospermic male 143
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 143
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 142
Cardiovascular remodeling, apoptosis, and drugs 141
Statins and progressive renal disease 141
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 141
The behaviour of serum triiodothyronine in autonomous thyroid nodules and its relationship with the clinical feature 141
The pleiotropic effects of erythropoietin in the central nervous system 137
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 137
Effects of lisinopril administration on blood bcl-2 concentrations in patients with immunoglobulin A nephropathy 137
Reduced bcl-2 concentrations in hypertensive patients after lisinopril or nifedipine administration 136
Osteoprotegerin, IL-6, IL-1, TNF-alpha and TGF-beta concentrations during acetate-free biofiltration 135
Kidney aging: From phenotype to genetics 134
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate. EUROPEAN UROLOGY, vol. 47; p. 575 - 581 133
Effetti del raloxifene sulla secrezione ipofisaria in post-menopausa 132
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 131
Management of patients after renal graft loss: an open question for nephrologists. 129
ELIZABETHAN STUDIES IN ITALY IN 1989 AND 1990 128
THE CIRCADIAN-RHYTHM OF ERYTHROPOIETIN IN SUBJECTS WITH PRE- TERMINAL UREMIA 125
Gastro-intestinal permeability is increased in patients with limited systemic sclerosis 125
Effect of a calcium antagonist, nifedipine, on the cold pressor test in normal subjects 124
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 124
Loss of circadian rhythm in erythropoietin production in a patient with renal erythropoietin secreting neoplasia 118
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 117
DOES ERYTHROPOIETIN AUGMENT THE CA2+-MEDIATED K+ FLOW INTO THE RED-BLOOD-CELLS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS 116
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 112
Recombinant human erythropoietin (rHuEPO): More than just the correction of uremic anemia 111
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 110
Flushing due to calcitonin and the opioid system 109
Plasma and erythrocyte magnesium concentrations in essential arterial hypertension 108
Does erythropoietin administration affect progression of atherosclerosis in Watanabe heritable hyperlipaemic rabbits? 108
Positive effects of the phytoestrogen genistein on bone metabolism in postmenopausal women 107
Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration 105
Effect of Growth Factors on the Potassium-Calcium induced efflux in vitro in wlole erythrocytes from hypertensive and pregnant subjects with gestation hypertension 105
Totale 15.995
Categoria #
all - tutte 66.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.477


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.208 0 263 13 26 62 10 59 39 56 225 133 322
2022/20232.829 203 272 128 221 251 279 25 193 1.107 34 85 31
2023/2024619 48 99 41 58 35 154 26 34 4 35 9 76
2024/20253.105 60 25 46 189 114 132 92 695 762 188 306 496
2025/20268.868 437 650 592 592 661 1.943 1.010 1.137 1.226 326 124 170
2026/2027754 274 480 0 0 0 0 0 0 0 0 0 0
Totale 20.358